Sugi Predict

Sugi Predict / Compounds / SCHEMBL202622

SCHEMBL202622

SCHEMBL202622

CC1(C)OB(c2ccc3c(c2)Cc2cc(B4OC(C)(C)C(C)(C)O4)ccc2-3)OC1(C)C

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LIPG Q9Y5X9 14/20 0.46
▸ LPL P06858 13/20 0.46
▸ CA1 P00915 2/20 0.39
▸ CA2 P00918 2/20 0.39
▸ CA9 Q16790 2/20 0.39
▸ CA12 O43570 1/20 0.39
▸ CA3 P07451 1/20 0.39
▸ CA4 P22748 1/20 0.39
▸ CA6 P23280 1/20 0.39
▸ CA5A P35218 1/20 0.39
▸ CA7 P43166 1/20 0.39
▸ CA14 Q9ULX7 1/20 0.39
▸ CA5B Q9Y2D0 1/20 0.39
▸ ROCK1 Q13464 1/20 0.39
▸ F11 P03951 1/20 0.38
▸ BACE1 P56817 1/20 0.36
▸ ESR2 Q92731 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30860136 1.00 LIPG (0.46) LIPGLPLCA1CA2CA9
SCHEMBL30079660 0.92 LPL (0.47) LIPGLPLROCK1BACE1
SCHEMBL29265 0.92 LPL (0.47) LIPGLPLROCK1BACE1
SCHEMBL29852098 0.91 LMNA (0.47) LIPGLPLCA1CA2CA9
SCHEMBL23294481 0.91 LMNA (0.47) LIPGLPLCA1CA2CA9
SCHEMBL204451 0.89 LPL (0.46) LIPGLPLCA1CA2CA9
SCHEMBL29851996 0.88 PGR (0.41) LIPGLPLCA1CA2CA9
SCHEMBL23294440 0.88 PGR (0.41) LIPGLPLCA1CA2CA9
SCHEMBL20109565 0.85 LIPG (0.47) LIPGLPLROCK1BACE1
SCHEMBL29502333 0.83 LPL (0.47) LIPGLPLCA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113838887-B Self-powered all-perovskite light-emitting diode 电子科技大学 2024-04-05 — — CN disclosed
US-11874278-B2 Reagents for directed biomarker signal amplification SIRIGEN II LIMITED (GB) 2024-01-16 — — US disclosed
US-11874278-B2 Reagents for directed biomarker signal amplification SIRIGEN II LIMITED (GB) 2024-01-16 — — US disclosed
US-11780831-B2 Compound, display panel and display apparatus Shanghai Tianma AM-OLED Co., Ltd. (CN) 2023-10-10 — — US disclosed
US-20230273215-A1 Novel Reagents for Directed Biomarker Signal Amplification SIRIGEN, INC. 2023-08-31 — — US disclosed
US-20230273215-A1 Novel Reagents for Directed Biomarker Signal Amplification SIRIGEN, INC. 2023-08-31 — — US disclosed
US-20230251264-A1 Novel Reagents for Directed Biomarker Signal Amplification SIRIGEN, INC. 2023-08-10 — — US disclosed
US-20230251264-A1 Novel Reagents for Directed Biomarker Signal Amplification SIRIGEN, INC. 2023-08-10 — — US disclosed
US-20230243837-A1 Novel Reagents for Directed Biomarker Signal Amplification SIRIGEN, INC. 2023-08-03 — — US disclosed
US-20230243837-A1 Novel Reagents for Directed Biomarker Signal Amplification SIRIGEN, INC. 2023-08-03 — — US disclosed
US-20100310512-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2010-12-09 — — US disclosed
WO-2010132601-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2010-11-18 — — WO disclosed
WO-2010132601-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2010-11-18 — — WO disclosed
EP-1475401-B1 Mono-, oligo- and polymers comprising fluorene and aryl groups MERCK PATENT GMBH (DE) 2009-05-27 — — EP disclosed
US-20090036643-A1 Conjugated monomers and polymers and preparation and use thereof NAVY, SECRETARY OF THE UNITED STATES OF AMERICA 2009-02-05 — — US disclosed
US-20090036643-A1 Conjugated monomers and polymers and preparation and use thereof NAVY, SECRETARY OF THE UNITED STATES OF AMERICA 2009-02-05 — — US disclosed
US-7199167-B2 Light emitting polymer UNIVERSITY OF HULL (GB) 2007-04-03 — — US disclosed
US-7126013-B2 Mono-, oligo- and polymers comprising fluorene and aryl groups MERCK PATENT GMBH (DE) 2006-10-24 — — US disclosed
EP-1475401-A2 Mono-, oligo- and polymers comprising fluorene and aryl groups MERCK PATENT GmbH (DE) 2004-11-10 — — EP disclosed
US-20040176560-A1 Mono-, Oligo-and polymers comprising fluorene and aryl groups MERCK PATENT GMBH (DE) 2004-09-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11874278-B2 Reagents for directed biomarker signal amplification RNGTT, CAPG, CA14 LIPG 961/4885LPL 3301/4885CA1 336/4885
US-20230243837-A1 Novel Reagents for Directed Biomarker Signal Amplification RNGTT, CAPG, CD2BP2 LIPG 1043/4885LPL 3659/4885CA1 541/4885
US-20230251264-A1 Novel Reagents for Directed Biomarker Signal Amplification RNGTT, CAPG, CD2BP2 LIPG 1043/4885LPL 3659/4885CA1 541/4885
US-20090036643-A1 Conjugated monomers and polymers and preparation and use thereof PCNA, HMGB1, HMGB3 LIPG 4276/4885LPL 2954/4885CA1 3482/4885
US-20230273215-A1 Novel Reagents for Directed Biomarker Signal Amplification RNGTT, CAPG, CD2BP2 LIPG 1043/4885LPL 3659/4885CA1 541/4885
US-11780831-B2 Compound, display panel and display apparatus C1S, DRD1, DRD3 LIPG 3838/4885LPL 1500/4885CA1 2681/4885
US-20100310512-A1 ANTIVIRAL COMPOUNDS MAVS, EIF2AK2, ZC3HAV1 LIPG 1280/4885LPL 2383/4885CA1 4745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.